Anlon Healthcare Incorporates New Subsidiary 'ANLON BIOLOGICS'

Anlon Healthcare Limited has successfully incorporated a new subsidiary, 'ANLON BIOLOGICS PRIVATE LIMITED', with effect from July 10, 2026. This move aligns with the company's long-term growth objectives and aims to strategically complement and expand its existing business in the pain management segment by manufacturing surgical implants and medical devices. The subsidiary will also focus on the development and manufacture of peptides, biosimilars, and biological compositions. Anlon Healthcare Limited holds a 65% stake in the newly incorporated entity, having subscribed to equity shares worth ₹650,000.